Targeting metabotropic glutamate receptors for the treatment of Parkinson's disease

被引：2
|
作者：
Huot, Philippe [1 ,2 ,3 ]
机构：
[1] Montreal Neurol Inst Hosp Neuro, Neurodegenerat Dis Grp, Montreal, PQ H3A 2B4, Canada
[2] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada
[3] McGill Univ, Dept Neurosci, Div Neurol, Movement Disorder Clin,Hlth Ctr, Montreal, PQ H3A 2B4, Canada
来源：
NEURODEGENERATIVE DISEASE MANAGEMENT | 2023年 / 13卷 / 04期
基金：
加拿大自然科学与工程研究理事会;
关键词：
dyskinesia; glutamate; metabotropic glutamate receptors; mGlu(2) receptors; mGlu(3) receptors; mGlu(4) receptors; mGlu(5) receptors; parkinsonism; Parkinson's disease; psychosis; LEVODOPA-INDUCED DYSKINESIA; MECHANISMS; AFQ056;
D O I：
10.2217/nmt-2023-0016
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：203 / 206
页数：4
相关论文
共 50 条
  • [31] The role of metabotropic glutamate receptors in Alzheimer's disease
    Lee, H
    Zhu, XW
    O'Neill, MJ
    Webber, K
    Casadesus, G
    Marlatt, M
    Raina, AK
    Perry, G
    Smith, MA
    ACTA NEUROBIOLOGIAE EXPERIMENTALIS, 2004, 64 (01) : 89 - 98
  • [32] Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease
    Dekundy, A
    Pietraszek, M
    Schaefer, D
    Cenci, MA
    Danysz, W
    BRAIN RESEARCH BULLETIN, 2006, 69 (03) : 318 - 326
  • [33] Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status
    Celli, Roberta
    Santolini, Ines
    Van Luijtelaar, Gilles
    Ngomba, Richard T.
    Bruno, Valeria
    Nicoletti, Ferdinando
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (04) : 341 - 351
  • [34] Targeting metabotropic glutamate receptors in neuroimmune communication
    Volpi, C.
    Fazio, F.
    Fallarino, F.
    NEUROPHARMACOLOGY, 2012, 63 (04) : 501 - 506
  • [35] Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's Disease and related disorders
    Rouse, ST
    Marino, MJ
    Bradley, SR
    Awad, H
    Wittmann, M
    Conn, PJ
    PHARMACOLOGY & THERAPEUTICS, 2000, 88 (03) : 427 - 435
  • [36] Effects of the blockade of subtype 1 metabotropic glutamate receptors (mGIuRs) in models of Parkinson's disease in the rat
    Ossowska, K
    Wardas, J
    Konieczny, J
    Pietraszek, M
    Zapala, M
    Wolfarth, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S370 - S370
  • [37] The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: Implications for the therapy of Parkinson's disease
    Wardas, J
    Pietraszek, M
    Wolfarth, S
    Ossowska, K
    NEUROSCIENCE, 2003, 122 (03) : 747 - 756
  • [38] Type-3 Metabotropic Glutamate Receptors and Parkinson's Disease: Preclinical Studies and Human Genetics
    Alborghetti, M.
    Di Menna, L.
    Traficante, A.
    Bruno, V.
    Monn, J.
    Nicoletti, F.
    Pontieri, F. E.
    Bianchini, E.
    Spalletta, G.
    Borro, M.
    Simmaco, M.
    Battaglia, G.
    MOVEMENT DISORDERS, 2020, 35 : S221 - S221
  • [39] PET studies: in vivo monitoring of group I metabotropic glutamate receptors in Parkinson's disease rat
    Yamasaki, T.
    Fujinaga, M.
    Kawamura, K.
    Shimoda, Y.
    Furutsuka, K.
    Nengaki, N.
    Yui, J.
    Wakizaka, H.
    Hatori, A.
    Xie, L.
    Kumata, K.
    Zhang, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S623 - S624
  • [40] The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer's Disease
    Abd-Elrahman, Khaled S.
    Sarasija, Shaarika
    Ferguson, Stephen S. G.
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (02) : 273 - 283
12345